Глава 6. Лечение хронического панкреатита • 429

cal results of pancreatic duct drainage, pancreatic secretion, and near total pancreatectomy and islet autotransplantation // Surgery.— 1984.— Vol.96.— P.608.

326. Mossner J., Secknus R., Meyer J. et al. Treatment of pain with pancreatic extracts in chron­ ic pancreatitis: results of a prospective placebo-controlled multicenter trial // Digestion.— 1992.-Vol.53.-P.54.

327. Nakad A., Piessevaux H., Marot J. С et al. Is early enteral nutrition in acute pancreatitis dangerous? About 20 patients fed by an endoscopically placed nasogastrojejunal tube // Pancreas.— 1998.-Vol.17 (2).—P.187—193.

328. Nakano S., Takayama Т., Ohki H. et al. Clinical evaluation of proton pump inhibitor E3810 (rabeprazole sodium) for the treatment of GERD // Mod. Physician.— 1994.— Vol.14.—P.I 16-123.

329. Napoleon В., Barthet M., Saurin J. et al. Endoscopic ampullectomy: Is the complication rate low enough to consider that it is an alternative treatment to surgery? Results of a mul- ticentrique retrospective study // Endoseopy.— 2003.— Vol.35 (Suppl. II).— P.57.

330. Nealon W. H., Townsend С M. Jr., Thompson J. С Operative drainage of the pancreatic duct delays functional impairment in patients with chronic pancreatitis: a prospective anal­ ysis // Ann. Surg.— 1988.— Vol.208.- P.321-329.

331. Neoptolemos J. P., Winslet M. С Pancreatic ascites.— In: Beger H. G., Buechler M. W., Ditschuneit H., Malferthainer P., eds. Chronic Pancreatitis.— Berlin — Heidelberg: Springer Verlag, 1990.- P.269-279.

332. Neuhaus H. Therapeutic pancreatic endoseopy // Endoseopy.—2004.—Vol. 36 (1).— P.8-16.

333. Nishi Т., Forgac M. The vacuolar (H+)-ATPases- nature's most versatile proton pumps // Nat. Rev. Mol. Cell. Biol.—2002.—Vol.3.—P.94—103.

334. Ohning G. V., Walsh J. H., Pisegna J. R. et al. Rabeprazole is superior to omeprazole for the inhibition of peptone meal-stimulated gastric acid secretion in Helicobacter pylori-neg­ ative subjects // Aliment. Pharmacol. Then- 2003.- Vol. 17 (9).— P.I 109—1114.

335. Oruc N., Ozutemiz A. O., Yukselen V. et al. Infliximab: a new therapeutic agent in acute pancreatitis? // Pancreas.- 2004.—Vol. 28 (1).— P.I—8.

336. Owyang C, Louie D., Tatum D. Feedback regulation of pancreatic enzyme secretion // J. Clin. Invest.- 1986.—Vol.77.- P.2042.

337. Pantoflickova D., Dorta G, Jornod P. et al. Identification of the characteristics influencing the degree of antisecretory activity of PPIs // Gastroenterology.— 2000.— Vol.4 (Suppl. 2).—P. 1290.

338. Pantoflickova D., Dorta G, Ravic M. et al. Acid inhibition on the first day of dosing: com­ parison of four proton pump inhibitors // Aliment Pharmacol. Ther.— 2003.— VoL17(I2).— P.1507—1514.

339. Pap A., Berger Z., Varro V. Trophic effect of cholecystikinin-octapeptide in man: a new way in the treatment of chronic pancreatitis? // Digestion.— 1981.— Vol.21.— P.163—168.

340. Pap A., Berger Z., Varro V. Beneficial effect of a soy flour diet in chronic pancreatitis // Mt. Sinai J. Med.- 1983,- Vol.50.- P.208—212.

341. Pap A, Varro V. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency // Hepatogastroenterol.— 1984.-Vol.31.-P.47—50.

342. Pap A., Berger Z., Varro V. Complementary effect of cholecystokinin-octapeptide and soy flour treatment in chronic pancreatitis // Mt. Sinai J. Med.— 1984.— Vol.51.— P.254—257.

343. Pap A., Flautner L., Tihanyi T. et al. Pancreatic function after endoscopic and surgical oc­ clusion of the pancreatic duct in patients with chronic pancreatitis // Endoseopy.— 1985.— Vol.17.— P.60-63.

344. Pap A., Flautner L., Karacsonyi S. et al. Recovery of pancreatic function after distal resec­ tion for chronic pancreatitis: regeneration or merely functional amelioration? // Mt. Sinai J. Med.- 1987.- Vol.54.- P.409-412.

345. Pap A., Varro V. Acid versus proteolytic inactivation of lipase. Comparison of the results of pancreatic replacement therapy with Panpur and Creon // Dig. Dis. Sci.— 1987.— Vol.32.—P.I 182.

346. Pap A., Varro V. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity // Hepatogastroen­ terol.— 1988.- Vol.35.- P.83-86.

347. Pap A. Pancreatic adaptation, growth and regeneration in experimental chronic pancreati­ tis.—In: Beger H. G., Bbchler M., Ditschuneit H., Maltfertheiner P., eds. Chronic Pan­ creatitis, Research and Clinical Management.— Berlin — Heidelberg: Springer-Verlag, 1990.—P.122-133.